Cargando…
The efficacy and safety of 5-fluorouracil/cisplatin/vincristine as a multi-agent chemotherapy regimen in gestational trophoblastic neoplasia
OBJECTIVE: To determine the efficacy and safety of the 5-fluorouracil (5-FU), cisplatin, and vincristine (FPV) chemotherapy regimen in patients with gestational trophoblastic neoplasia (GTN). METHODS: We performed a retrospective study of 96 GTN patients with International Federation of Gynecology a...
Autores principales: | Wang, Lu, Wang, Qian, Xu, Zhen, Yang, Linli, Wang, Wuliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644366/ https://www.ncbi.nlm.nih.gov/pubmed/38023226 http://dx.doi.org/10.3389/fonc.2023.1240972 |
Ejemplares similares
-
Real-World Study of Cisplatin, Etoposide, and Bleomycin Chemotherapy Regimen in Gestational Trophoblastic Neoplasia
por: Wang, Ming, et al.
Publicado: (2021) -
Single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
por: Mousavi Seresht, Leila, et al.
Publicado: (2023) -
Resistance to single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
por: Sheikhhasani, Shahrzad, et al.
Publicado: (2023) -
Monotherapy for low-risk gestational trophoblastic neoplasia with score 5-6
por: Kemin, Li, et al.
Publicado: (2022) -
Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/ etoposide and cisplatin) regimen in gestational trophoblastic neoplasia
por: Aminimoghaddam, Soheila, et al.
Publicado: (2018)